Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

O'Neill, 2016

O'Neill, 2014

de Kraker, 2016, Will 10 million people die a year due to antimicrobial resistance by 2050?, PLoS Med, 13, 10.1371/journal.pmed.1002184

2016

2019

Prestinaci, 2015, Antimicrobial resistance: a global multifaceted phenomenon, Pathog Glob Health, 109, 309, 10.1179/2047773215Y.0000000030

2015

Naylor, 2018, Estimating the burden of antimicrobial resistance: a systematic literature review, Antimicrob Resist Infect Control, 7, 58, 10.1186/s13756-018-0336-y

Cassini, 2019, Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis, Lancet Infect Dis, 19, 56, 10.1016/S1473-3099(18)30605-4

Lim, 2016, Epidemiology and burden of multidrug-resistant bacterial infection in a developing country, eLife, 5, 10.7554/eLife.18082

Temkin, 2018, Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study, Lancet Glob Health, 6, e969, 10.1016/S2214-109X(18)30278-X

de Kraker, 2021, Burden of antimicrobial resistance: compared to what?, Epidemiol Rev, 10.1093/epirev/mxab001

Vos, 2020, Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet, 396, 1204, 10.1016/S0140-6736(20)30925-9

Hay, 2018, Measuring and mapping the global burden of antimicrobial resistance, BMC Med, 16, 78, 10.1186/s12916-018-1073-z

Murray, 2012, GBD 2010: design, definitions, and metrics, Lancet, 380, 2063, 10.1016/S0140-6736(12)61899-6

Dunachie, 2020, The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria, Curr Opin Microbiol, 57, 95, 10.1016/j.mib.2020.09.013

Limmathurotsakul, 2019, Improving the estimation of the global burden of antimicrobial resistant infections, Lancet Infect Dis, 19, e392, 10.1016/S1473-3099(19)30276-2

Ashley, 2018, An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000, J Antimicrob Chemother, 73, 1737, 10.1093/jac/dky026

Fullman, 2018, Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016, Lancet, 391, 2236, 10.1016/S0140-6736(18)30994-2

Browne, 2021, Global antibiotic consumption in humans, 2000 to 2018: a spatial modelling study, Lancet Planet Health

Singer, 2016, The third international consensus definitions for sepsis and septic shock (sepsis-3), JAMA, 315, 801, 10.1001/jama.2016.0287

Rudd, 2020, Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study, Lancet, 395, 200, 10.1016/S0140-6736(19)32989-7

2020

Angus, 2001, Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care, Crit Care Med, 29, 1303, 10.1097/00003246-200107000-00002

Martin, 2003, The epidemiology of sepsis in the United States from 1979 through 2000, N Engl J Med, 348, 1546, 10.1056/NEJMoa022139

Rhee, 2017, Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014, JAMA, 318, 1241, 10.1001/jama.2017.13836

Zheng, 2021, Trimmed constrained mixed effects models: formulations and algorithms, J Comput Graph Stat, 0, 1

2014

Murray, 2020, Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet, 396, 1223, 10.1016/S0140-6736(20)30752-2

2021

2017

2019

2020

2020

2017

Burki, 2017, Tuberculosis missing from WHO bacteria list, Lancet Respir Med, 5, 252, 10.1016/S2213-2600(17)30090-5

Castro

2019

Jansen, 2018, The role of vaccines in preventing bacterial antimicrobial resistance, Nat Med, 24, 10, 10.1038/nm.4465

Klugman, 2018, Impact of existing vaccines in reducing antibiotic resistance: primary and secondary effects, Proc Natl Acad Sci USA, 115, 12896, 10.1073/pnas.1721095115

Tang, 2017, Restricting the use of antibiotics in food-producing animals and its associations with antibiotic resistance in food-producing animals and human beings: a systematic review and meta-analysis, Lancet Planet Health, 1, e316, 10.1016/S2542-5196(17)30141-9

Van Boeckel, 2019, Global trends in antimicrobial resistance in animals in low- and middle-income countries, Science, 365, 10.1126/science.aaw1944

Ter Kuile, 2016, The risk of low concentrations of antibiotics in agriculture for resistance in human health care, FEMS Microbiol Lett, 363, 10.1093/femsle/fnw210

Wu, 2013, Comparative analysis of ESBL-positive Escherichia coli isolates from animals and humans from the UK, the Netherlands and Germany, PLoS One, 8

Mather, 2013, Distinguishable epidemics of multidrug-resistant Salmonella Typhimurium DT104 in different hosts, Science, 341, 1514, 10.1126/science.1240578

Holmes, 2016, Understanding the mechanisms and drivers of antimicrobial resistance, Lancet, 387, 176, 10.1016/S0140-6736(15)00473-0

Cox, 2017, Antibiotic stewardship in low- and middle-income countries: the same but different?, Clin Microbiol Infect, 23, 812, 10.1016/j.cmi.2017.07.010

Rolfe, 2021, Barriers to implementing antimicrobial stewardship programs in three low- and middle-income country tertiary care settings: findings from a multi-site qualitative study, Antimicrob Resist Infect Control, 10, 60, 10.1186/s13756-021-00929-4

2019

2018

Morgan, 2011, Non-prescription antimicrobial use worldwide: a systematic review, Lancet Infect Dis, 11, 692, 10.1016/S1473-3099(11)70054-8

Laxminarayan, 2013, Antibiotic resistance—the need for global solutions, Lancet Infect Dis, 13, 1057, 10.1016/S1473-3099(13)70318-9

Kelesidis, 2015, Substandard/counterfeit antimicrobial drugs, Clin Microbiol Rev, 28, 443, 10.1128/CMR.00072-14

Collignon, 2018, Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis, Lancet Planet Health, 2, e398, 10.1016/S2542-5196(18)30186-4

Ramay, 2020, Antibiotic use and hygiene interact to influence the distribution of antimicrobial-resistant bacteria in low-income communities in Guatemala, Sci Rep, 10, 10.1038/s41598-020-70741-4

Hendriksen, 2019, Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage, Nat Commun, 10, 10.1038/s41467-019-08853-3

Mera, 2011, Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion, Microb Drug Resist, 17, 321, 10.1089/mdr.2010.0193

Delorme, 2017, A longitudinal analysis of methicillin-resistant and sensitive Staphylococcus aureus incidence in respect to specimen source, patient location, and temperature variation, Int J Infect Dis, 54, 50, 10.1016/j.ijid.2016.11.405

Oldenkamp, 2021, Filling the gaps in the global prevalence map of clinical antimicrobial resistance, Proc Natl Acad Sci USA, 118, 10.1073/pnas.2013515118

Ombelet, 2018, Clinical bacteriology in low-resource settings: today's solutions, Lancet Infect Dis, 18, e248, 10.1016/S1473-3099(18)30093-8

Humphries, 2019, Understanding and addressing CLSI breakpoint revisions: a primer for clinical laboratories, J Clin Microbiol, 57, e00203, 10.1128/JCM.00203-19